AlphAIAlphAI — Financial news for AI agents
SEC EDGARJUL 312 min read$ISRG

Brosius Mark sold $20K of ISRG

Brosius Mark (EVP & Chief Mfg and Supply Cha) sold 56 shares of INTUITIVE SURGICAL INC (ISRG) at an average of $348.92 ($346.83–$351.00) across 2 trades over 2026-07-30 to 2026-07-31 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Brosius Mark
Published Jul 31, 2026, 9:59 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 31, 2026, 10:02 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$ISRG
Neutral
high confidence
Mentioned
$ISRG
Relevance
2/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ISRGNeutralLow
01

Why it matters

The only new fact is the reported open-market sale by an officer (EVP and Chief Mfg and Supply Chain) totaling about $19.5K across two trades, executed under a pre-arranged 10b5-1 plan.

02

Market read

Traders may note insider selling, but the 10b5-1 structure and small dollar amount make it low-signal for price discovery.

03

What to watch

The sale size is small relative to a mega-cap, and the filing does not disclose any new operational or financial information.

Relevance 2/10Novelty 3/10Timing: filed 2026-07-31 after-hours

Background

The article is an SEC Form 4 insider transaction disclosure for Intuitive Surgical (ISRG).

Company-level read

Ticker impact

$ISRGNeutralHigh confidence
Context

Form 4 shows ISRG EVP Mark Brosius sold 56 shares in two open-market trades for about $19.5K under a pre-arranged 10b5-1 plan.

Expected impact

Low likelihood of a sustained price reaction; any effect is likely short-lived and sentiment-driven.

Evidence & confidence

The filing is an insider transaction, not an earnings, guidance, deal, or regulatory event. The presence of a pre-arranged 10b5-1 plan reduces interpretive value.

Market effects

Sector

No direct sector read-through; this is company-specific insider trading disclosure.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

Even with a 10b5-1 plan, repeated insider selling can still reflect personal liquidity needs rather than bearish expectations, so the market may ignore it.

Key entities

  • public_company
    ISRG

    Intuitive Surgical, issuer of the Form 4 insider transaction.

  • insider
    Brosius Mark

    Officer (EVP and Chief Mfg and Supply Chain) who sold shares.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

ISRG insider trading history →

Related articles

SEP 30
$ISRGHighAI 8/10

Intuitive receives CE mark for da Vinci 5 cardiac procedures

Intuitive Surgical (ISRG) received CE mark approval for its da Vinci 5 system in cardiac procedures, including coronary artery bypasses and thoracoscopic cardiotomy. The company aims to expand its robotic-assisted cardiac surgery offerings in Europe, with a dedicated team and partnerships with select centers. ISRG previously received FDA clearance for cardiac use in January.

massdevice.com2 min
SEP 29
$ISRGHighAI 8/10

Intuitive Surgical Gains CE Mark for Cardiac Robotics

Intuitive Surgical received CE mark approval for its da Vinci surgical robot to perform cardiac procedures in adults, including minimally invasive coronary artery bypass. This approval allows Intuitive to compete with rivals Medtronic and Johnson & Johnson in the surgical robotics space. The company aims to expand its cardiac surgery offerings globally, following FDA clearance for cardiovascular procedures in January.

mddionline.com3 min
SEP 15
$ISRGHighAI 8/10

Intuitive receives CE mark for transvaginal use of da Vinci SP system

Intuitive Surgical (ISRG) received CE mark approval for its da Vinci SP system for transvaginal gynecological procedures in Europe, expanding its use in women's health. The system, already approved for other surgeries, allows single-incision operations, potentially improving recovery and outcomes. It is also approved in the US, Japan, and Korea.

yahoo.com2 min
SEP 14
$ISRGHigh

Intuitive announces expanded indication for da Vinci SP in Europe

Intuitive (ISRG) received CE mark approval for transvaginal gynecologic procedures using the da Vinci SP system in Europe, expanding its applications. The approval allows for less invasive options and potentially better recovery experiences. The system is already approved in the US, Japan, and Korea for various procedures.

prnewswire.com2 min